Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P.
Transplantation Proceedings 22(3): 1336-1338
1990
ISSN/ISBN: 0041-1345 PMID: 2190396 Document Number: 359052
Document emailed within 1 workday
Related Documents
Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96Bykova, T.A.; Kozlov, A.V.; Stancheva, N.V.; Semënova, E.V.; Kulagina, I.I.; Bondarenko, S.N.; Vavilov, V.N.; Morozova, E.V.; Zubarovskaia, L.S.; Afanas'ev, B.V. 2013: Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation Terapevticheskii Arkhiv 85(8): 60-68
Przepiorka, D.; Shapiro, S.; Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Shadduck, R.K.; Venkataramanan, R. 1991: Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease Bone Marrow Transplantation 7(6): 461-465
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Bacigalupo, A.; Frassoni, F.; Van Lint, M.T.; Occhini, D.; Gualandi, F.; Lamparelli, T.; Vitale, V.; Scarpati, D.; Clavio, M.; Marmont, A.M. 1989: Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission Haematologica 74(5 Suppl): 425-432
Brok, H.P.; Heidt, P.J.; van der Meide, P.H.; Zurcher, C.; Vossen, J.M. 1993: Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice Journal of Immunology 151(11): 6451-6459
Tong, J.; Viale, M.; Bacigalupo, A.; Podestà, M.; Sogno, G.; Tedone, E.; Marmont, A.M. 1992: Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation Haematologica 77(4): 365-366
Smyth, L.A.; Witt, C.S.; Christiansen, F.T.; Herrmann, R.P.; Hollingsworth, P.N.; Townend, D.C.; Edward, E.; Dawkins, R.L. 1993: The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation Bone Marrow Transplantation 12(4): 351-355
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
Nevo, S.; Enger, C.; Swan, V.; Wojno, K.J.; Fuller, A.K.; Altomonte, V.; Braine, H.G.; Noga, S.J.; Vogelsang, G.B. 1999: Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival Transplantation 67(5): 681-689
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Martin-Algarra, S.; Bishop, M.R.; Tarantolo, S.; Cowles, M.K.; Reed, E.; Anderson, J.R.; Vose, J.M.; Bierman, P.; Armitage, J.O.; Kessinger, A. 1995: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Experimental Hematology 23(14): 1503-1508
Imoto, S.; Oomoto, Y.; Murata, K.; Das, H.; Murayama, T.; Kajimoto, K.; Sugimoto, T.; Gomyo, H.; Nakagawa, T.; Nishimura, R.; Koizumi, T. 2000: Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease International Journal of Hematology 72(1): 92-97
Fauser, A.A.; Shustik, C.; Langleben, A.; Laurent, G.; Kanz, L.; Spurll, G.M.; Price, G.; Ahlgren, P.D.; Cooper, B.A. 1988: T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 40-46
Mengarelli, A.; Iori, A.Paola.; Romano, A.; Cerretti, R.; Cerilli, L.; De Propris, M.Stefania.; Fenu, S.; Moleti, M.Luisa.; De Felice, L.; Girelli, G.; Arcese, W. 2003: One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation Haematologica 88(3): 315-323
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Carayol, G.; Bourhis, J.H.; Guillard, M.; Bosq, J.; Pailler, C.; Castagna, L.; Vernant, J.P.; Pico, J.L.; Hayat, M.; Chouaib, S.; Caignard, A. 1997: Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease Transplantation 63(9): 1307-1313
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696